{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:02:12Z","timestamp":1780696932214,"version":"3.54.1"},"reference-count":10,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T00:00:00Z","timestamp":1137369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p> <jats:sc>l<\/jats:sc>\u2010asparaginase is active in the treatment of acute lymphoblastic leukaemia (ALL) through the depletion of serum asparagine. Here we report that median asparagine synthetase (<jats:italic>AS<\/jats:italic>) mRNA levels were higher in acute myeloid leukaemia (AML) than ALL blasts in both children and adults, with intermediate levels in normal peripheral blood mononuclear cells (NPBMC). NPBMC <jats:italic>versus<\/jats:italic> child ALL (Tukeys multiple comparison test, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b705); child ALL <jats:italic>versus<\/jats:italic> child AML (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001) and adult ALL <jats:italic>versus<\/jats:italic> adult AML (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701) were all significant and support the hypothesis that selectivity to treatment with <jats:sc>l<\/jats:sc>\u2010asparaginase is due, at least in part, to lower <jats:italic>AS<\/jats:italic> expression.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05945.x","type":"journal-article","created":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T14:17:54Z","timestamp":1137421074000},"page":"740-742","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"132","author":[{"given":"M.","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Coulthard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,2,13]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1016\/S0021-9258(19)44748-0","article-title":"Glutamine\u2010dependent asparagine synthetase from leukemia cells. Chloride dependence, mechanism of action, and inhibition","volume":"247","author":"Horowitz B.","year":"1972","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"C1691","DOI":"10.1152\/ajpcell.1997.272.5.C1691","article-title":"Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells","volume":"272","author":"Hutson R.G.","year":"1997","journal-title":"American Journal of Physiology"},{"key":"e_1_2_5_4_1","first-page":"294","article-title":"Biochemical characterization of U937 cells resistant to l\u2010asparaginase: the role of asparagine synthetase","volume":"3","author":"Kiriyama Y.","year":"1989","journal-title":"Leukemia"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403259"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403574"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403577"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402880"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2446"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403576"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400834"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05945.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05945.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:42:49Z","timestamp":1697431369000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05945.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,13]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05945.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05945.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,13]]},"assertion":[{"value":"2006-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}